The hyperphosphatemia and elevated fibroblast growth factor 23 (FGF23) caused by SHPT may induce brain edema by disrupting cerebral vascular autoregulation and may also inhibit neuronal energy metabolism (Gong et al., 2020; Drew et al., 2020). The gene discussed is FGF23; the disease is hyperphosphatemia.